ATE225174T1 - Selbstemulgierende formulierung enthaltend saure lipophile verbindungen - Google Patents

Selbstemulgierende formulierung enthaltend saure lipophile verbindungen

Info

Publication number
ATE225174T1
ATE225174T1 AT98936888T AT98936888T ATE225174T1 AT E225174 T1 ATE225174 T1 AT E225174T1 AT 98936888 T AT98936888 T AT 98936888T AT 98936888 T AT98936888 T AT 98936888T AT E225174 T1 ATE225174 T1 AT E225174T1
Authority
AT
Austria
Prior art keywords
self
emulsifying formulation
pharmaceutically acceptable
formulation containing
containing acidic
Prior art date
Application number
AT98936888T
Other languages
English (en)
Inventor
Walter Morozowich
Ping Gao
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE225174T1 publication Critical patent/ATE225174T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT98936888T 1997-07-29 1998-07-27 Selbstemulgierende formulierung enthaltend saure lipophile verbindungen ATE225174T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5401297P 1997-07-29 1997-07-29
PCT/US1998/014817 WO1999006044A1 (en) 1997-07-29 1998-07-27 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation

Publications (1)

Publication Number Publication Date
ATE225174T1 true ATE225174T1 (de) 2002-10-15

Family

ID=21988155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936888T ATE225174T1 (de) 1997-07-29 1998-07-27 Selbstemulgierende formulierung enthaltend saure lipophile verbindungen

Country Status (24)

Country Link
US (1) US6231887B1 (de)
EP (1) EP0989851B1 (de)
JP (1) JP4524367B2 (de)
KR (1) KR100509131B1 (de)
CN (1) CN1112927C (de)
AT (1) ATE225174T1 (de)
AU (1) AU728626B2 (de)
BR (1) BR9810729B1 (de)
CA (1) CA2294033C (de)
CY (1) CY2006002I2 (de)
CZ (1) CZ296957B6 (de)
DE (1) DE69808463T2 (de)
DK (1) DK0989851T3 (de)
ES (1) ES2184310T3 (de)
FI (1) FI20000172A7 (de)
HU (1) HU228923B1 (de)
NO (1) NO323425B1 (de)
NZ (1) NZ502566A (de)
PL (1) PL192865B1 (de)
PT (1) PT989851E (de)
RU (1) RU2202346C2 (de)
SI (1) SI0989851T1 (de)
SK (1) SK284616B6 (de)
WO (1) WO1999006044A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
ATE287714T1 (de) * 1999-03-31 2005-02-15 Upjohn Co Pharmazeutische emulsionen für retroviral- protease hemmende verbindungen
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
DE60132103T2 (de) * 2000-10-31 2008-04-17 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Perorale, selbst-emulgierende darreichungsformen von pyranon-proteaseinhibitoren
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
EP1613353A1 (de) * 2003-04-02 2006-01-11 Boehringer Ingelheim International GmbH Pharmazeutische zusammensetzungen für protease-hemmer für hepatitis-c-virus
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
JP2007507226A (ja) * 2003-10-07 2007-03-29 イーライ リリー アンド カンパニー ラクトパミンの液状製剤
WO2006055660A2 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and uk-427, 857
WO2006055754A1 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
US20060142344A1 (en) * 2004-12-01 2006-06-29 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and GW695634
JP5028885B2 (ja) * 2006-07-04 2012-09-19 大正製薬株式会社 ユビデカレノン含有自己乳化組成物
CN101631568B (zh) 2007-03-12 2012-08-22 尼克塔治疗公司 低聚物-蛋白酶抑制剂偶联物
US9095620B2 (en) * 2008-03-12 2015-08-04 Nektar Therapeutics Reagents
JP2012530069A (ja) 2009-06-12 2012-11-29 ネクター セラピューティックス プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体
MY154683A (en) 2009-07-07 2015-07-15 Boehringer Ingelheim Int Pharmaceutical composition for a hepatitis c viral protease inhibitor
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
RU2419426C1 (ru) * 2010-04-26 2011-05-27 Всеволод Иванович Киселев Лекарственное средство на основе дииндолилметана (dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
US10842770B2 (en) 2010-05-03 2020-11-24 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
EP2943183A1 (de) * 2013-01-14 2015-11-18 InFirst Healthcare Limited Zusammensetzungen und verfahren zur behandlung von starken schmerzen
CA2976952A1 (en) * 2015-03-05 2016-09-09 Allergan, Inc. Self-emulsifying drug delivery system (sedds) for ophthalmic drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230702A (en) 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
DE3300793A1 (de) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
GB8903804D0 (en) 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
IL102236A0 (en) * 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
GB9208712D0 (en) * 1992-04-22 1992-06-10 Sandoz Ltd Pharmaceutical compositions containing cyclosporin derivates
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
IL129871A (en) 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
WO1996003113A1 (en) * 1994-07-22 1996-02-08 G.D. Searle & Co. Self-emulsifying drug delivery system
US5965160A (en) * 1995-04-24 1999-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
ES2182996T3 (es) 1995-06-06 2003-03-16 Hoffmann La Roche Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido.
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.

Also Published As

Publication number Publication date
NO323425B1 (no) 2007-04-30
JP2002510330A (ja) 2002-04-02
CN1261796A (zh) 2000-08-02
SK284616B6 (sk) 2005-07-01
RU2202346C2 (ru) 2003-04-20
CN1112927C (zh) 2003-07-02
US6231887B1 (en) 2001-05-15
DE69808463D1 (de) 2002-11-07
PL338335A1 (en) 2000-10-23
BR9810729B1 (pt) 2010-07-13
WO1999006044A1 (en) 1999-02-11
NZ502566A (en) 2002-03-28
ES2184310T3 (es) 2003-04-01
EP0989851B1 (de) 2002-10-02
HU228923B1 (en) 2013-06-28
CA2294033A1 (en) 1999-02-11
CZ2000156A3 (cs) 2000-05-17
DK0989851T3 (da) 2003-01-27
SK162000A3 (en) 2000-12-11
KR100509131B1 (ko) 2005-08-18
KR20010022369A (ko) 2001-03-15
DE69808463T2 (de) 2003-06-26
EP0989851A1 (de) 2000-04-05
PT989851E (pt) 2002-12-31
CY2006002I2 (el) 2012-01-25
HK1028879A1 (en) 2001-03-09
CA2294033C (en) 2007-01-09
SI0989851T1 (en) 2003-04-30
PL192865B1 (pl) 2006-12-29
CY2006002I1 (el) 2011-02-02
AU728626B2 (en) 2001-01-11
FI20000172L (fi) 2000-01-28
FI20000172A7 (fi) 2000-01-28
HUP0002440A3 (en) 2001-10-29
CZ296957B6 (cs) 2006-08-16
NO20000466L (no) 2000-03-28
HUP0002440A2 (hu) 2001-09-28
NO20000466D0 (no) 2000-01-28
AU8573898A (en) 1999-02-22
BR9810729A (pt) 2000-08-08
JP4524367B2 (ja) 2010-08-18

Similar Documents

Publication Publication Date Title
ATE225174T1 (de) Selbstemulgierende formulierung enthaltend saure lipophile verbindungen
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
DE69804624D1 (de) Selbstemulgierende formulierung enthaltend lipophile verbindungen
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
HUP0301972A2 (hu) Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény
YU21803A (sh) Farmaceutski aktivni derivati sulfonamida koji imaju i lipofilne i jonizujuće osobine kao inhibitori protein-junkinaza
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
BRPI0116237B8 (pt) "composto de sulfamida, composição farmacêutica contendo o mesmo e seu uso como medicamento antagonista de receptor de endotelina".
IL149163A0 (en) Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
EP0882450A3 (de) Cholesterinsenkende Zusammensetzung enthaltend Coenzym Q
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
ATE321543T1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
EP1193256A8 (de) Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
DE69805860D1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
NO950177D0 (no) Farmakologisk aktive erivater
IT1291278B1 (it) Preparazione farmaceutica a base di nimesulide per uso topico
EA200000261A2 (ru) Новые замещенные димерные соединения, способ их получения и содержащая их фармацевтическая композиция
DE60017720D1 (de) Pharmazeutische emulsionen für retroviral-protease hemmende verbindungen
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
TH77238A (th) สารสูตรผสมที่คล้ายกับไซโคลสปอริน
TR200102196T2 (tr) Mono-asiloksi aralkil nöromuskular relaksanları.